Skip to main content
S 2045 107th Congress Senate International Affairs American economic assistance Commerce Congress Congress and foreign policy Congressional reporting requirements Drug therapy Health International agencies Medical statistics Nongovernmental organizations Pharmaceutical research Preventive medicine Public-private partnerships Science, Technology, Communications Tuberculosis World health

International Tuberculosis Control Act of 2002

Introduced: March 21, 2002 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 21, 2002
Read twice and referred to the Committee on Foreign Relations. (text of measure as introduced: CR S2266-2267)
Mar 21, 2002
Sponsor introductory remarks on measure. (CR S2266)
Mar 21, 2002
Introduced in Senate
 Plain-English summary Congressional Research Service
International Tuberculosis Control Act of 2002 - Amends the Foreign Assistance Act of 1961 to revise requirements for assistance for health programs in developing countries to declare that Congress recognizes that the means exist to control and treat the growing international problem of tuberculosis by implementing the Global Plan to Stop Tuberculosis and investing in new mechanisms like the Global Tuberculosis Drug Facility. Makes it a major objective of the foreign assistance program to control the disease.

Declares that Congress expects the agency primarily responsible for administering this Act to: (1) coordinate with the World Health Organization (WHO), the Centers for Disease Control, the National Institutes of Health, and other organizations with respect to the development and implementation of a comprehensive tuberculosis control program; and (2) set specified deadlines for the detection of at least 70 percent of the cases of infectious tuberculosis, and the cure of at least 85 percent of them.

Earmarks specified amounts of funds for antituberculosis drugs, supplies, patient services, and training in diagnosis and care in order to increase directly observed treatment shortcourse (DOTS) coverage, including funding for the Global Tuberculosis Drug Facility.

What's happening now March 21, 2002

Read twice and referred to the Committee on Foreign Relations. (text of measure as introduced: CR S2266-2267)

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1